Consolidated Portfolio Review Corp »

Ishares Tr genomics immun shares owned by Consolidated Portfolio Review Corp

Quarter-by-quarter ownership of Ishares Tr genomics immun (IDNA) shares owned by Consolidated Portfolio Review Corp from 13F filings

Historical chart of Consolidated Portfolio Review Corp investment in Ishares Tr genomics immun

Tip: Access up to 7 years of quarterly data

All positions including Ishares Tr genomics immun held by Consolidated Portfolio Review Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ishares Tr genomics immun by Consolidated Portfolio Review Corp

Quarter filed Position value Share count Share price at filing
2024-03-31 $339k 14k 24.08
2023-12-31 $305k 13k 23.01
2023-09-30 $220k 11k 20.35
2023-06-30 $312k 13k 23.35
2023-03-31 $355k 15k 23.27